Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $122.5 million.

  • Praxis Precision Medicines' Non-Current Assets rose 11801.88% to $122.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $492.7 million, marking a year-over-year increase of 17037.34%. This contributed to the annual value of $78.7 million for FY2024, which is 246642.76% up from last year.
  • Praxis Precision Medicines' Non-Current Assets amounted to $122.5 million in Q3 2025, which was up 11801.88% from $146.3 million recorded in Q2 2025.
  • In the past 5 years, Praxis Precision Medicines' Non-Current Assets registered a high of $146.3 million during Q2 2025, and its lowest value of $3.1 million during Q4 2023.
  • Its 4-year average for Non-Current Assets is $47.0 million, with a median of $5.0 million in 2022.
  • As far as peak fluctuations go, Praxis Precision Medicines' Non-Current Assets crashed by 2845.15% in 2023, and later skyrocketed by 246642.76% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Non-Current Assets (Quarter) stood at $4.3 million in 2022, then fell by 28.45% to $3.1 million in 2023, then skyrocketed by 2466.43% to $78.7 million in 2024, then soared by 55.64% to $122.5 million in 2025.
  • Its Non-Current Assets was $122.5 million in Q3 2025, compared to $146.3 million in Q2 2025 and $145.2 million in Q1 2025.